COMPASS THERAPEUTICS

Serial Number 86566697
606

Registration Progress

Application Filed
Mar 17, 2015
Under Examination
Jan 19, 2016
Approved for Publication
Nov 24, 2015
Published for Opposition
Nov 24, 2015
Registered

Trademark Image

COMPASS THERAPEUTICS

Basic Information

Serial Number
86566697
Filing Date
March 17, 2015
Published for Opposition
November 24, 2015
Abandonment Date
February 25, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 25, 2019
Classes
001 005

Rights Holder

COMPASS THERAPEUTICS LLC

16
Address
245 First Street, 3rd Floor
Cambridge, NH 02142

Ownership History

Kairos Biologics Foundation LLC

Original Applicant
16
Hanover, NH

COMPASS THERAPEUTICS LLC

New Owner Before Publication #1
16
HANOVER, NH

COMPASS THERAPEUTICS LLC

Owner at Publication
16
Cambridge, NH

Legal Representation

Attorney
Philip R. Zender, Esquire

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description
Feb 25, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 25, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 21, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 20, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 20, 2018 EX5G S SOU EXTENSION 5 GRANTED
Jul 16, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 16, 2018 EXT5 S SOU EXTENSION 5 FILED
Dec 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 19, 2017 EXT4 S SOU EXTENSION 4 FILED
Dec 19, 2017 EX4G S SOU EXTENSION 4 GRANTED
Jul 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 14, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 14, 2017 EXT3 S SOU EXTENSION 3 FILED
Jul 14, 2017 EX3G S SOU EXTENSION 3 GRANTED
Jan 20, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 18, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 18, 2017 EXT2 S SOU EXTENSION 2 FILED
Jan 18, 2017 EX2G S SOU EXTENSION 2 GRANTED
Jul 8, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 6, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 6, 2016 EXT1 S SOU EXTENSION 1 FILED
Jul 6, 2016 EX1G S SOU EXTENSION 1 GRANTED
Jan 19, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 24, 2015 PUBO A PUBLISHED FOR OPPOSITION
Nov 24, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2015 ALIE A ASSIGNED TO LIE
Oct 22, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 18, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED
Sep 18, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 18, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2015 CNRT R NON-FINAL ACTION WRITTEN
Jun 26, 2015 GNRT F NON-FINAL ACTION E-MAILED
Jun 26, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2015 DOCK D ASSIGNED TO EXAMINER
Jun 3, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 26, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2015 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Antibodies for scientific and research purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Antibody therapeutic preparations for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"